Consonance Capital Management LP Tandem Diabetes Care Inc Transaction History

Consonance Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$53.22 - $123.09 $7.61 Million - $17.6 Million	-143,033 Reduced 97.09%	4,294 $254,000
Q1 2022 May 16, 2022	SELL	$101.89 - $150.09 $15.6 Million - $23 Million	-153,337 Reduced 51.0%	147,327 $17.1 Million
Q4 2021 Feb 14, 2022	SELL	$118.18 - $153.21 $22.1 Million - $28.6 Million	-186,663 Reduced 38.3%	300,664 $45.3 Million
Q3 2021 Nov 15, 2021	SELL	$93.51 - $129.4 $46 Million - $63.7 Million	-491,899 Reduced 50.23%	487,327 $58.2 Million
Q2 2021 Aug 16, 2021	BUY	$77.0 - $100.19 $75.4 Million - $98.1 Million	979,226 New	979,226 $95.4 Million
Q1 2020 May 15, 2020	SELL	$47.37 - $90.04 $26.1 Million - $49.6 Million	-550,956 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$53.13 - $71.19 $25 Million - $33.6 Million	-471,301 Reduced 46.1%	550,956 $32.8 Million
Q3 2019 Nov 14, 2019	BUY	$57.11 - $73.3 $58.4 Million - $74.9 Million	1,022,257 New	1,022,257 $60.3 Million

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.97B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.